Synonyms: IL-17 modulator 4
Compound class:
Synthetic organic
Comment: This is a small synthetic molecule that has been demonstrated to disrupt the interaction between the two monomer peptides of the functional interleukin 17A (IL-17A) homodimer (IL-17AA) [1]. Compound 23 was designed as an orally bioavailable agent, for potential to disrupt IL-17A signalling via the IL-17 receptor (principally the IL-17RA/IL-17RC heterodimer), to induce an anti-inflammatory effect in diseases like psoriasis, which are driven by abnormally high IL-17AA expression levels. The 3D structure of compound 23 in complex with the human IL-17AA dimer has been resolved by X-ray crystallography (PDB ID 7AMA). The chemical and physical properties of compound 23 satisfy Lipinski's rule of five for druglikeness [2].
|
|
Bioactivity Comments |
Compound 23 inhibits IL-8 release by HEKa cells that have been costimulated with glycosylated IL-17A and TNFα, with an EC50 of 14 nM. |
Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|